1Yoo K Y, Jeong S W, Kim S J, et al. Cardio vascular re- sponses to endotracheal intubationg in patients with acute and chronic spinal cord injuries[J]. Anesth Analg, 2003, 97(4) : 1164.
2[2]Amin HM,Sopchak AM,Esposito BF,et al.Naloxone-induced and spontaneous reversal of depressed ventilatory responses to hypoxia during and after continuous infusion of remifentanil or alfentanil[J].J Pharmacol Exp Ther,1995,274(1):34-39.
3[3]Reves JG.Educational considerations for the clinical introduction and use of remifentanil[J].Anesth Analg,1999,89(Suppl 4):4-6.
4[4]Glass PS,Hardman D,Kamiyama Y,et al.Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid:remifentanil(GI87084B)[J].Anesth Analg,1993,77(5):1031-1040.
5[5]Dershwitz M,Hoke JF,Rosow CE,et al.Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease[J].Anesthesiology,1996,84(4):812-820.
6[6]Hoke JF,Shlugman D,Dershwitz M,et al.Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteers[J].Anesthesiology,1997,87(3):533-541.
7[7]Jhaveri R,Joshi P,Batenhorst R,et al.Dose comparison of remifentanil and alfentanil for loss of consciousness[J].Anesthesiology,1997,87(2):253-259.
8[8]Lang E,Kapila A,Shlugman D,et al.Reduction of isoflurane minimal alveolar concentration by remifentanil[J].Anesthesiology,1996,85(4):721-728.
9[9]Westmoreland CL,Hoke JF,Sebel PS,et al.Pharmacokinetisc of remifentanil(GI87084B) and its major metabolite(GI9029) in patients undergoing elective inpatient surgery[J].Anesthesiology,1993,79(5):893-903.
10[10]Sebel PS,Hoke JF,Westmoreland C,et al.Histamine concentrations and hemodynamic responses after remifentanil[J].Anesth Analg,1995,80(5):990-993.
